FORGOT PASSWORD?


Continue with login
OR
IQOS_Lithuania_research_USA_risk_heating_tobacco

Positive news from the IQOS research analysis

IQOS is the only tobacco heating system to be recognised as a modified-risk tobacco product by the US Food and Drug Administration (FDA), which is responsible for protecting public health and has very strict requirements for product safety. The FDA has stated that a complete transition from regular cigarettes to IQOS reduces the body’s exposure to harmful, or potentially harmful, substances.*

After analysing the IQOS research results, the US Food and Drug Administration concluded that:
— IQOS heats tobacco without burning it.
— Eliminating the burning process significantly reduces the emission of harmful, or potentially harmful, chemicals.
— Scientific research shows that after a complete transition from regular cigarettes to IQOS, the potentially harmful substances have significantly less impact on the human body**.

This decision by the FDA shows that IQOS is a completely different product than cigarettes, and offers a better choice for adult smokers who do not intend to quit smoking.

IQOS_Lithuania_research_FDA_heating_tobacco_smoking

This federal agency is responsible for protecting public health in the United States. The organisation plays an important role in assessing the safety and efficacy of drugs, biological and cosmetic products, as well as medical devices. In order to protect public health and reduce smoking in young people, the FDA is responsible for regulating the production and marketing of tobacco products, and is one of the few agencies in the world to have a special procedure for evaluating modified-risk products.

IQOS is not a risk-free product. The nicotine contained in heated tobacco products is addictive.

More news is coming soon.

* PMI three-month lower-impact research conducted in Japan and the United States, in conditions that are extremely close to real-life situations. The studies measured the effects of 15 selected chemicals on the selected biomarkers, and compared how these markers changed in people who switched to IQOS compared to those who continued to smoke cigarettes throughout the study.

** On 7 July 2020, the FDA issued guidance on the marketing and consumer information about IQOS as a modified-risk product.

Product added to cart

Your cart is empty

Find the IQOS that suits you best.

Compare models

This site contains information on a product containing tobacco and is reserved for smokers over 18 years old residing in Lithuania.
Are you a smoker over 18 years old?
Check

This site contains information on a product, which is for adults only. The website is reserved for smokers over 18 years old.

For more information about Philip Morris International or its products, visit pmi.com